R. You

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Diamant Thaçi, Andrew Blauvelt, Kristian Reich et al. · Journal of the American Academy of Dermatology · 2015 · 537 citations · Full text

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

Andrew Blauvelt, Kristian Reich, Tsen‐Fang Tsai et al. · Journal of the American Academy of Dermatology · 2016 · 301 citations

Inflammation, Immunology, Clear Study +6

Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (<scp>JUNCTURE</scp>)

C. Paul, J.‐P. Lacour, L. Tedremets et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 275 citations

Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial

Alice B. Gottlieb, John Sullivan, Martijn B. A. van Doorn et al. · Journal of the American Academy of Dermatology · 2016 · 150 citations · Full text

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled <scp>TRANSFIGURE</scp> trial

Kristian Reich, John Sullivan, Petr Arenberger et al. · British Journal of Dermatology · 2018 · 98 citations